Loading ...

poly(lactide-co-glycolide)/tetraethylene glycol(ibuprofen)2 nanospheres

Based on

1 Patents
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

poly(lactic-co-glycolic acid)

poly(lactide-co-glycolide) P2191 PLGA PLGA
Type Polymer
Formula
Role raw materials
2

tetraethylene glycol(ibuprofen)2

ibuprofen derivative Ibu2TEG
Type Single Compound
Formula C34H50O7
Role loaded material

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • tetraethylene glycol(ibuprofen)2
  • poly(lactic-co-glycolic acid)
  1. 7XXzpDoXYNdalJHl6mRJEJb54p4s7cInK7H9VA7XR
Product

poly(lactide-co-glycolide)/tetraethylene glycol(ibuprofen)2 nanospheres

Size: 107 - 203 nm

Medium: water

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial